We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI Outperforms Humans at Analyzing Long-Term ECG Recordings

By HospiMedica International staff writers
Posted on 18 Feb 2025

The human heart beats 80,000-120,000 times a day, and long-term ECGs record every heartbeat, which are then analyzed for abnormalities—arrhythmias. More...

This analysis is a labor-intensive process. Ambulatory ECGs must be examined by specially trained personnel, known as ECG technicians, but there is a global shortage of approximately 15 million healthcare workers. This shortage creates significant bottlenecks in healthcare, and at the same time, patients could benefit from more extensive and longer ambulatory ECG recordings rather than shorter ones. Now, a new study has shown that an artificial intelligence (AI) network algorithm designed to interpret ambulatory ECG signals can surpass humans in analyzing long-term ECG recordings.

The study conducted by researchers at Lund University (Lund, Sweden) and Population Health Research Institute (PHRI, Hamilton, ON, Canada) included 14,606 individual patients who recorded an average of 14 days of ECG data, totaling over 200,000 days of ECG data. These data were initially reviewed by ECG technicians using standard clinical methods. The same data were then re-analyzed using the DeepRhythmAI algorithm, developed by MEDICALgorithmics (Warsaw, Poland), specifically for this task. The results, published in Nature Medicine, demonstrated that the AI analysis resulted in 14 times fewer missed diagnoses of severe arrhythmias, such as complete heart block, ventricular tachycardia, and atrial fibrillation. The AI missed severe arrhythmias in 0.3% of patients, compared to 4.4% for the technicians.

The AI model was able to rule out severe arrhythmia with 99.9% confidence in a 14-day ECG recording. The number of false positives, where serious arrhythmias were misinterpreted, was relatively low—12 per 1,000 recording days for the AI compared to 5 per 1,000 recording days for human analysis. This study is the first to evaluate not just the AI’s ability to assess individual ECG strips, but also to explore what would happen if human technicians were replaced by AI. The researchers aimed not to compare AI’s performance with cardiologists in diagnosing specific arrhythmias, but to assess the potential impact of replacing technicians and having physicians receive reports directly from AI. If successful, this approach could represent a major innovation, helping to address the global shortage of trained staff for interpreting long-term ECG monitoring.

“Today, most long-term ECG devices use some type of AI to support interpretation, but with varying quality,” said Jeff Healey, senior scientist at the PHRI. “And there are still long waiting times for long-term ECG monitoring, in some cases many months. If we have a qualified AI model that can review all ECGs, then we would have both much cheaper and faster diagnostics.”

Related Links:
Lund University
PHRI
MEDICALgorithmics


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gold Member
Blood Gas Analyzer
i-Check200
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.